Technology
Health
Medical

iRadimed

$21.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.99 (-4.43%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell iRadimed and other stocks, options, ETFs, and crypto commission-free!

About

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. Read More The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Employees
95
Headquarters
Winter Springs, Florida
Founded
1992
Market Cap
249.18M
Price-Earnings Ratio
35.88
Dividend Yield
0.00
Average Volume
88.94K
High Today
$22.36
Low Today
$21.05
Open Price
$22.29
Volume
18.86K
52 Week High
$38.78
52 Week Low
$18.25

Collections

Technology
Health
Medical
Advertising and Marketing
Medical Devices
Business Services
2014 IPO
US

News

Yahoo FinanceMay 3

A Look At IRadimed Corporation's (NASDAQ:IRMD) Exceptional Fundamentals

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Attractive stocks have exceptional fundamentals. In the case of IRadimed Corporation (NASDAQ:IRMD), there's is a financially-sound company with a great track record and a excellent growth outlook. In the following section, I expand a bit more on these key aspects. If you're interested in understanding beyond my broad commentary, read the full report on IRadimed here. High growth pote...

18
The Motley FoolApr 30

Iradimed (IRMD) Q1 2019 Earnings Call Transcript

Iradimed (NASDAQ:IRMD) Q1 2019 Earnings Call April 30, 2019 11:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Ladies and gentlemen, thank you for standing by. Welcome to the IRadimed Corporation first-quarter 2019 financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded today, April 30, 2019, and contains time-sensitive information that is accurate only as of today. Earlier, IRadimed re...

23
Simply Wall StApr 27

Are IRadimed Corporation’s (NASDAQ:IRMD) High Returns Really That Great?

Today we are going to look at IRadimed Corporation (NASDAQ:IRMD) to see whether it might be an attractive investment prospect. Specifically, we’re going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. Firstly, we’ll go over how we calculate ROCE. Then we’ll compare its ROCE to similar companies. Finally, we’ll look at how its current liabilities affect its ROCE. What is Return On Capital Employed (ROCE)? ROCE is a metric for evaluating how much ...

1

Earnings

$0.03
$0.07
$0.12
$0.16
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.